Cryptotanshinone is a candidate therapeutic agent for interstitial lung disease associated with a BRICHOS-domain mutation of SFTPC

Interstitial lung disease (ILD) represents a large group of diseases characterized by chronic inflammation and fibrosis of the lungs, for which therapeutic options are limited. Among several causative genes of familial ILD with autosomal dominant inheritance, the mutations in the BRICHOS domain of S...

Descripción completa

Detalles Bibliográficos
Autores principales: Hosokawa, Motoyasu, Mikawa, Ryuta, Hagiwara, Atsuko, Okuno, Yukiko, Awaya, Tomonari, Yamamoto, Yuki, Takahashi, Senye, Yamaki, Haruka, Osawa, Mitsujiro, Setoguchi, Yasuhiro, Saito, Megumu K., Abe, Shinji, Hirai, Toyohiro, Gotoh, Shimpei, Hagiwara, Masatoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494175/
https://www.ncbi.nlm.nih.gov/pubmed/37701577
http://dx.doi.org/10.1016/j.isci.2023.107731

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494175/
https://www.ncbi.nlm.nih.gov/pubmed/37701577
http://dx.doi.org/10.1016/j.isci.2023.107731

Ejemplares similares